SCHEMBL22154387

SCHEMBL22154387

N#Cc1ccc2c3ccccc3n(-c3cccc(-c4ccc(C#N)c(-n5c6ccccc6c6ccc(-n7c8ccccc8c8ccccc87)cc65)c4)c3)c2c1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAT2A P31153 2/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
G6PD P11413 1/20 0.32
TDP2 O95551 1/20 0.32
PLA2G10 O15496 1/20 0.31
PLA2G2A P14555 1/20 0.31
DHFR P00374 1/20 0.31
PDPK1 O15530 1/20 0.31
RPS6KB1 P23443 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22153387 1.00 ALDH1A1 (0.36) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22152530 0.96 ALDH1A1 (0.35) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22152500 0.96 ALDH1A1 (0.35) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22153388 0.96 ALDH1A1 (0.35) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22153966 0.96 ALDH1A1 (0.35) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22152511 0.93 KDM4E (0.35) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22153269 0.93 KDM4E (0.35) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22153944 0.93 KDM4E (0.36) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22153260 0.93 KDM4E (0.36) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22153822 0.92 KDM4E (0.33) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALDH1A1 1500/4885LMNA 1535/4885HPGD 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.